Unbreakable? An analysis of the fragility of randomized trials that support diabetes treatment guidelines

We found that the robustness of RCTs varied, but on the whole were not robust in nature. Most trials demonstrated a modest FI and FQ. As a result, conclusions drawn from these trials should take this information into account.